Loading data
UVENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.6 bn USD | 1.52 bn USD | 1.39 bn USD | 1.22 bn USD | 1.12 bn USD |
| Selling, general and administrative expense | — | 342.08 m USD | 304.07 m USD | 304.9 m USD | 313.6 m USD |
| Interest expense | — | — | 6.53 m USD | 6.61 m USD | 638 k USD |
| Profit before tax | 243.07 m USD | 84.61 m USD | 88.35 m USD | -27.25 m USD | 28.41 m USD |
| Income tax expense | 60.12 m USD | 25.68 m USD | 21.53 m USD | -4.99 m USD | 8.01 m USD |
| Net income (reported basis) | 182.95 m USD | 58.93 m USD | 66.82 m USD | -22.26 m USD | 20.41 m USD |
| Net income attributable to common shareholders | 182.94 m USD | 58.92 m USD | 66.81 m USD | -22.27 m USD | 20.4 m USD |
| Basic earnings per share | 6.56 USD/share | 2.07 USD/share | 2.24 USD/share | -0.72 USD/share | 0.65 USD/share |
| Diluted earnings per share | 6.32 USD/share | 2.01 USD/share | 2.22 USD/share | -0.72 USD/share | 0.65 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.